Company intelligence / Profile preview
BIOPHTA
Paris, Île-de-France, Francebiophta.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
BIOPHTA is a preclinical-stage biotech company developing a patented ophthalmic insert that delivers continuous, controlled drug dosing to the eye for up to 7 days. The technology aims to replace invasive intraocular injections and improve patient adherence in treating major causes of blindness such as glaucoma and macular edema. The company has raised €6.5 million in seed funding to advance its lead programs into Phase 1 clinical trials starting in 2025 for glaucoma and in 2026 for macular edema[2][4].
- Therapeutic areas
- Ophthalmology
- Modalities
- Ophthalmic inserts (topical, non-invasive drug delivery)Biopolymer-based hydrogel technology ("thiomer" biopolymers)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Unither PharmaceuticalsHTL Biotechnology
Beyond the preview
Go deeper on BIOPHTA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BIOPHTA.